News Articles
Latest articles, insights, and updates from the blog.
Need help or want to reach readers?
Have a correction, provider question, or advertising inquiry? Reach the editorial team.
Compass Pathways: Extra COMP360 Dose Extends Relief to 1 Year
Compass Pathways reports 52-week open-label data from its COMP005 trial showing a second COMP360 psilocybin dose extended benefit. Here's what patients should know.
New Study Examines Ketamine and Opioid Receptors
A reported study links ketamine to opioid receptor activation. Here is what the early finding may, and may not, mean for patients.
Considering Ketamine Therapy? How to Stay Safe
Ketamine therapy is growing in popularity for depression and mental health, but safety depends on screening, monitoring, and provider choice.
Veterans, First Responders Discuss Ketamine Therapy
Veterans and first responders in Callahan County, Texas shared their experiences with ketamine-assisted therapy. Here's what patients should know about the evidence and access.
Ketamine and Psychedelics May Alter Brain Immunity
New research reported by Neuroscience News suggests ketamine and psychedelics may alter brain immune signaling linked to depression symptoms.
UT Health San Antonio Adds Ketamine to Amputee Care
UT Health San Antonio's Limb Optimization Program now includes ketamine therapy for amputees. Here's what patients should know about this multidisciplinary approach.
Federal Probe Targets Online Ketamine Sellers
Federal officials are investigating online ketamine sellers, WSJ reports. What this regulatory scrutiny means for patients considering at-home ketamine therapy.
COMP360 Phase 3 Data Confirms Rapid TRD Relief
Six-month data from a second Phase 3 trial of COMP360 psilocybin confirms rapid antidepressant effects for treatment-resistant depression. What patients should know.
Why Ketamine Therapy Is Booming Across America
Ketamine use is surging across the U.S. for reasons beyond the drug itself. Here's what patients and families evaluating ketamine therapy need to understand.
Healing With IV Ketamine: Local TV Covers Patient Stories
A Kansas City TV segment highlights IV ketamine therapy's healing potential. Here's what patients and families should consider before starting treatment.
MedShadow Foundation Shares Key Ketamine Depression Facts
MedShadow Foundation releases important facts about ketamine as an antidepressant. Learn what patients should know before considering treatment.
Local TV News Highlights IV Ketamine Treatment Hope
FOX 4 Kansas City covers IV ketamine therapy as a new healing path, signaling growing mainstream acceptance of ketamine treatments.
GH Research Reports Phase 2 Results for Depression Treatment
GH Research reports Phase 2 results for GH001 in postpartum and treatment-resistant depression. Analysis of implications for ketamine patients.